ES2170271T3 - Derivados de la 4a,5a,8a,8b-tetrahidro-6h-pirrolo(3',4':4,5)furo(3,2-b)piridin-6,8(7h)diona para la lucha contra los endoparasitos y procedimientos para su obtencion. - Google Patents

Derivados de la 4a,5a,8a,8b-tetrahidro-6h-pirrolo(3',4':4,5)furo(3,2-b)piridin-6,8(7h)diona para la lucha contra los endoparasitos y procedimientos para su obtencion.

Info

Publication number
ES2170271T3
ES2170271T3 ES96934560T ES96934560T ES2170271T3 ES 2170271 T3 ES2170271 T3 ES 2170271T3 ES 96934560 T ES96934560 T ES 96934560T ES 96934560 T ES96934560 T ES 96934560T ES 2170271 T3 ES2170271 T3 ES 2170271T3
Authority
ES
Spain
Prior art keywords
pirrolo
piridin
furo
derivatives
tetrahidro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934560T
Other languages
English (en)
Inventor
Peter Jeschke
Achim Harder
Norbert Mencke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2170271T3 publication Critical patent/ES2170271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRESENTE INVENCION TRATA DEL EMPLEO, PARA LA LUCHA ENDOPARASITARIA, DE DERIVADOS DE 4A,5A,8A,8B TETRAHIDRO 6H PIRROLO[3 ,4 :4,5]FURO[3,2-B]PIRIDIN 6,8(7H) DION DE FORMULA GENERAL (I) Y DE SUS SALES; EN LA FORMULA, LOS RADICALES DE R 1 A R 5 TIENEN LA SIGNIFICACION DADA EN LA DESCRIPCION. LA INVENCION TRATA ASIMISMO DE LOS DERIVADOS DE 4A,5A,8A,8B TETRAHIDRO 6H PIRROLO[3 ,4 :4,5]FURO[3,2B]PIRIDIN 6,8(7H) DION Y DEL PROCEDIMIENTO PARA SU PRODUCCION.
ES96934560T 1995-10-19 1996-10-07 Derivados de la 4a,5a,8a,8b-tetrahidro-6h-pirrolo(3',4':4,5)furo(3,2-b)piridin-6,8(7h)diona para la lucha contra los endoparasitos y procedimientos para su obtencion. Expired - Lifetime ES2170271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19538960A DE19538960A1 (de) 1995-10-19 1995-10-19 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2170271T3 true ES2170271T3 (es) 2002-08-01

Family

ID=7775277

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934560T Expired - Lifetime ES2170271T3 (es) 1995-10-19 1996-10-07 Derivados de la 4a,5a,8a,8b-tetrahidro-6h-pirrolo(3',4':4,5)furo(3,2-b)piridin-6,8(7h)diona para la lucha contra los endoparasitos y procedimientos para su obtencion.

Country Status (24)

Country Link
US (2) US6110928A (es)
EP (1) EP0871630B1 (es)
JP (1) JP4157163B2 (es)
KR (1) KR100444144B1 (es)
CN (1) CN1111535C (es)
AR (1) AR004023A1 (es)
AT (1) ATE211475T1 (es)
AU (1) AU706836B2 (es)
BR (1) BR9611002B1 (es)
CZ (1) CZ295075B6 (es)
DE (2) DE19538960A1 (es)
DK (1) DK0871630T3 (es)
ES (1) ES2170271T3 (es)
HK (1) HK1017359A1 (es)
HU (1) HUP9802854A3 (es)
NO (1) NO323609B1 (es)
NZ (1) NZ320174A (es)
PL (1) PL185960B1 (es)
PT (1) PT871630E (es)
SK (1) SK284914B6 (es)
TR (1) TR199800686T2 (es)
TW (1) TW466241B (es)
WO (1) WO1997014695A1 (es)
ZA (1) ZA968788B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719839A1 (de) * 1997-05-12 1998-11-19 Bayer Ag 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten
DE10201544A1 (de) * 2002-01-17 2003-07-31 Bayer Cropscience Ag Substituierte Pyrazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032090A1 (de) * 1990-02-13 1991-08-14 Bayer Ag Polycyclische 3-aryl-pyrrolidin-2,4-dion-derivate
DE4121365A1 (de) * 1991-06-28 1993-01-14 Bayer Ag Substituierte 1-h-3-aryl-pyrrolidin-2,4-dion-derivate

Also Published As

Publication number Publication date
PL326323A1 (en) 1998-09-14
AU706836B2 (en) 1999-06-24
BR9611002B1 (pt) 2010-11-30
JP4157163B2 (ja) 2008-09-24
EP0871630A1 (de) 1998-10-21
AR004023A1 (es) 1998-09-30
HUP9802854A2 (hu) 1999-05-28
AU7286596A (en) 1997-05-07
DE19538960A1 (de) 1997-04-24
CZ118898A3 (cs) 1998-08-12
NO981502D0 (no) 1998-04-02
HUP9802854A3 (en) 2001-12-28
CN1111535C (zh) 2003-06-18
HK1017359A1 (en) 1999-11-19
SK49298A3 (en) 1998-09-09
CN1204335A (zh) 1999-01-06
ATE211475T1 (de) 2002-01-15
EP0871630B1 (de) 2002-01-02
BR9611002A (pt) 1999-07-13
PL185960B1 (pl) 2003-09-30
CZ295075B6 (cs) 2005-05-18
KR19990063812A (ko) 1999-07-26
DE59608617D1 (de) 2002-02-28
NO323609B1 (no) 2007-06-18
US6291472B1 (en) 2001-09-18
US6110928A (en) 2000-08-29
NO981502L (no) 1998-04-02
KR100444144B1 (ko) 2005-01-13
TW466241B (en) 2001-12-01
TR199800686T2 (xx) 1998-07-21
WO1997014695A1 (de) 1997-04-24
NZ320174A (en) 2000-12-22
DK0871630T3 (da) 2002-04-29
PT871630E (pt) 2002-06-28
ZA968788B (en) 1996-12-03
SK284914B6 (sk) 2006-02-02
JPH11513675A (ja) 1999-11-24

Similar Documents

Publication Publication Date Title
ES2161290T3 (es) Derivados de quinazolina.
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
MX9307940A (es) Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
ATE244564T1 (de) Felbamat-derivate
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2098790T3 (es) Derivados de 1,2,3,5,6,7,8,8a-octahidro-5,5,8a-trimetil-(8abeta)-6-isoquinoleinamina, su procedimiento de preparacion y su empleo en terapeutica.
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
GEP20033052B (en) Tricyclic Sulfonamides and Their Derivatives As Inhibitors of Matrix Metalloproteinases
ES2162110T3 (es) Derivados de la quinolina antimalaria.
AR024380A1 (es) Tienopirimidinas
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
IT1247509B (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
ES2158996T3 (es) Agonistas beta3 adrenergicos selectivos.
AR040579A1 (es) Derivados de fenilalanina enamida
ES2170271T3 (es) Derivados de la 4a,5a,8a,8b-tetrahidro-6h-pirrolo(3',4':4,5)furo(3,2-b)piridin-6,8(7h)diona para la lucha contra los endoparasitos y procedimientos para su obtencion.
ES2195158T3 (es) Amidas de alfa-aminoacidos, su preparacion y el uso terapeutico de las mismas.
PA8525101A1 (es) Nuevos derivados de aminociclohexanol
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
ECSP003590A (es) Compuestos calcioliticos
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR008858A1 (es) Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 871630

Country of ref document: ES